rs759641927
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_002180.3(IGHMBP2):c.1156T>C(p.Trp386Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,613,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002180.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251136Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135790
GnomAD4 exome AF: 0.0000458 AC: 67AN: 1461538Hom.: 0 Cov.: 32 AF XY: 0.0000440 AC XY: 32AN XY: 727096
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74352
ClinVar
Submissions by phenotype
Autosomal recessive distal spinal muscular atrophy 1;C4015349:Charcot-Marie-Tooth disease axonal type 2S Pathogenic:2
This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 386 of the IGHMBP2 protein (p.Trp386Arg). This variant is present in population databases (rs759641927, gnomAD 0.006%). This missense change has been observed in individual(s) with spinal muscular atrophy with respiratory distress (SMARD), Charcot-Marie-Tooth disease type 2 (CMT2), and with hereditary motor and sensory neuropathy (PMID: 17431882, 25439726; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 573815). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt IGHMBP2 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
- -
Distal spinal muscular atrophy Uncertain:2
- -
- -
Inborn genetic diseases Pathogenic:1
The c.1156T>C (p.W386R) alteration is located in exon 8 (coding exon 8) of the IGHMBP2 gene. This alteration results from a T to C substitution at nucleotide position 1156, causing the tryptophan (W) at amino acid position 386 to be replaced by an arginine (R). Based on data from gnomAD, the C allele has an overall frequency of 0.002% (7/282524) total alleles studied. The highest observed frequency was 0.005% (6/129074) of European (non-Finnish) alleles. This alteration was detected in conjunction with another alteration in IGHMBP2, in multiple individuals with features of IGHMBP2-related neuropathy (Kulshrestha, 2018; Cottenie, 2014; Guenther, 2007). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. -
Autosomal recessive distal spinal muscular atrophy 1 Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at